ArticleSignal transduction and targeted therapy2022

Gefitinib and fostamatinib target EGFR and SYK to attenuate silicosis: a multi-omics study with drug exploration.

Mingyao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.